Eligo Bioscience

In vivo microbiome gene-editing technologies for developing targeted therapies for human disease

Paris, FranceFounded 2014eligo.bio Website technologies

Highlights

Hiring1 open role
New on EvolcAdded 2026-10-30

About Eligo Bioscience

Eligo Bioscience develops DNA-delivery and gene-editing technologies that modify bacterial populations in the microbiome. Its platform includes targeted antimicrobials, genome editing and methods for adding microbial functions.

The company is based in Paris and was founded in 2014. Its team works in synthetic biology, microbiology, immunology and therapeutic development; current hiring includes operations and general administration.

Product: A proprietary platform for delivering therapeutic DNA to bacterial populations to edit microbiome composition and function.

Jobs at Eligo Bioscience (1)

Eligo Bioscience is hiring for one role in leadership, based in Paris.

Chief of Staff
Paris, FranceHead3 days ago
New on Evolc

Leadership

Xavier Duportet · Founder, CEO & Board Director
Source: company website
Aurélie Grienenberger · Chief Operating Officer
Source: company website

More biotech & pharma companies

Emka Technologies
Telemetry, ECG and physiological monitoring systems and software for preclinical research labs working with rodents and large animals
Paris, FranceBiotech & pharmaFounded 20081 open job
New on EvolcRemote-friendly
Enyo Pharma
Clinical-stage biopharma developing oral vonafexor for chronic kidney disease and Alport syndrome
Lyon, FranceBiotech & pharmaFounded 2014
New on Evolc
Ephyla
Biotech cosmetic active ingredient development for cosmetics and dermocosmetics companies
Arzal, FranceBiotech & pharmaFounded 2009
New on Evolc
Epigene Labs
Oncology data and bioinformatics tools for biopharma researchers developing precision cancer therapies
Paris, FranceBiotech & pharmaFounded 2019
New on Evolc
Everzom
Develops exosome-based therapeutics and biomanufacturing for regenerative medicine and biotech partners
Strasbourg, FranceBiotech & pharmaFounded 2019
New on Evolc
Fabentech
Develops antibody-based emergency treatments for governments and health organizations facing biological threats
Lyon, FranceBiotech & pharmaFounded 2009
New on Evolc